Olanzapine (Zyprexa) is approved to treat schizophrenia in adults and children ages 13 years and older, manic and mixed episodes related to bipolar I disorder in adults and children ages 13 years and ...

Atypical antipsychotic drugs are a mainstay of psychiatric pharmacotherapy and are used to treat a variety of psychiatric illnesses, most notably schizophrenia. These second generation drugs lack the ...

Olanzapine represents a second-generation atypical antipsychotic agent that is currently approved for the treatment of psychotic disorders, schizophrenia, schizoaffective disorders, mania, and other ...

For years, the antipsychotic olanzapine (Zyprexa, Lilly) has been used off label for chemotherapy-induced nausea and vomiting (CINV), but the currently recommended 10-mg dose causes daytime sedation.

Olanzapine is an atypical antipsychotic drug of the thienobenzodiazepine group and has become a prominent part of psychiatric clinical practice over the past two decades. Still, adverse reactions to ...

Olanzapine is an atypical antipsychotic, prescribed for schizophrenia. We recommend consulting your doctor to verify the information presented on this page or if you need any further clarifications.

Discover comprehensive details about Olanzapine and Fluoxetine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Please provide your email address to receive an email when new articles are posted on . Olanzapine and prochlorperazine reduced nausea compared with placebo for people with symptoms after chemotherapy ...

The FDA has warned of a rare but serious skin reaction that can be progressive with the antipsychotic drug olanzapine and related products. The agency is adding a new warning to all ...

Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus ...

In a randomized, double-blind, phase 3 trial, we compared olanzapine with placebo, in combination with dexamethasone, aprepitant or fosaprepitant, and a 5-hydroxytryptamine type 3–receptor antagonist, ...